Lecture 5- Neurulation: Mechanisms of neural tube formation Flashcards

1
Q

What is neural induction?

A

-the specification of the dorsal ectoderm to a neural fate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is neurulation?

A

-embryonic process that generates the neural tube

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the neural plate undergo during development into the neural tube?

A
  • morphogenic changes: shaping, bending and folding
  • neural plate bends and edges elevate
  • neural crest migration is the final step in the neural tube closure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Where are the presumptive/future neural crest, and epidermis in relation to the neural plate?

A

-the neural folds fuse in the midline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does amphibian neuralation differ from human neuralation?

A

-in amphibians neural tube closes as a simultaneous event along all neuroaxial levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does neural plate do during neuralation?

A

-bends and elevates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do the dorsal margins of the neural tube do at the end of neuralation?

A

-fuse together “zip”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is the mechanism of neural tube formation similar in humans and mice?

A
  • yes
  • the timing is different but the principle is the same
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a neuropore?

A
  • marks where neuralation is occuring
  • openings in the closing neural tube
  • reduce in size as neural tube closure proceeds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the three neuropores in a mouse embryo?

A
  1. Hindbrain neuropore
  2. Rostral/anterior neuropore
  3. Posterior neuropore
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is neuralation initiated?

A

-at multiple sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a closure site?

A

-position where neuralation is initiated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What signifies the end of neuralation?

A

-neuropore closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many closure sites are there in a mouse embryo?

A

-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where is neuralation initiated? (mouse embryo)

A

-at closure 1 in both directions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How many neuropores and closure sites are there in a human embryo?

A
  • 2 neuropores, anterior and posterior
  • 2 closure sites (1 and 3)
  • existence of closure 2 in humans is controversial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does failure of neural tube closure cause?

A

-neural tube defects NTDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the three most common neural tube defects in humans and why do they arise?

A
  1. Craniorachischisis: failure of initiation from closure 1, completely open from midbrain to spine, lethal
  2. Anencephaly: failure of rostral (anterior) neuropore closure, lethal
  3. Spina bifida: failure of caudal (posterior) neuropore closure, wheelchair-bound, loss of function below the lesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is anencephaly a result of (mouse)?

A

-failure of initiation from closure 2 or failure of anterior neuropore closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is open spina bifida (myelomeningocele) in a mouse a result of?

A

-failure of posterior neuropore closure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is craniorachischisis a result of? (mouse)

A

-failure of initiation from Closure 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What happens to the exposed neural tissue when the neural tube fails to close?

A
  • results in degeneration of exposed neural tissue in utero
  • this is why in spina bifida you have a loss of function
  • with anecephaly, the brain develops but degenerates in utero
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How common are neural tube defects in humans and what are the two most common defects?

A
  • 1 in every 1000 pregnancies
  • spina bifida and anencephaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the cause of neural tube defects?

A
  • multifactorial and complex
  • major genetic component in NTD susceptibility (but pattern of inheritance is sporadic)
  • many candidate genes
  • most human cases predict to involve multiple genes and a contribution from environmental factors
25
Q

What is used as the primary prevention of neural tube defects in humans?

A

-maternal intake of folic acid

26
Q

Can neural tube defects be repaired surgically?

A
  • possible for early open spina bifida in utero
  • carries many risks
  • rate of miscarriage is high
27
Q

What happens to the neural tube during neuralation?

A

-neural plate is shaped, bent, and fused along the midline

28
Q

What are the four cellular and molecular steps of neuralation?

A
  1. neural plate shaping: cellular- convergent extension, molecular- planar cell polarity pathway (PCP)
  2. Elevation and apposition: cellular- hinge point formation, molecular- sonic hedgehog BMP pathway
  3. Adhesion and fusion: cellular- dorsal midline fusion of neural folds, cell protrusion, molecular- adhesion molecules
  4. Closure and remodelling: cellular-separation of the neural tube and surface ectoderm
29
Q

What happens during 1. Neural plate shaping? (cellular)

A
  • neural plate becomes narrower and longer, broad cranial region, narrow spinal region
  • convergent extension: narrowing and lengthening of tissue without additional cell growth
  • tissue undergoes simultaneous narrowing (convergence) along one axis and lengthening (extension) along another axis
30
Q

What are the processes in 1. Neural plate shaping? (2)

A
  1. Collective migration: cells move in one direction as a cohesive sheet, no neighbour exchange, neural plate cells move towards the midline of the embryo
  2. Cell intercalation: cells change shape and exchange neighbours, neural plate cells redistribute in the anterior-posterior axis
31
Q

What process does cell intercalation involve?

A
  • protrusion of cellular processes
  • cells form polarised protrusions (lamellpodia)
  • protrusions attach and crawl on negbouring cells creating traction and tension
  • tension elongates and pulls cells between one another (intercalation)= narrower and longer tissue
32
Q

How is convergent extension regulated at the molecular level?

A
  • by the PCP (Planar Cell Polarity) pathway
  • also called non-canonical Wnt signalling pathway
33
Q

What is the PCP (or the non-canonical Wnt signalling) pathway like?

A
  • the PCP pathway is activated via binding of Wnt to Fz (the frizzled receptor) on the cell membrane
  • the Fz receptor recruits Dsh (Dishevelled protein) which uses its PDZ and DEP domain to form a complex with Dishevelled-associated activator of morphogenesis 1 (DAAM1)
  • DAAM1 then activates the protein Rho
  • Rho activates Rho-associated kinase (ROCK) that is one of the major regulators of the cytoskeleton
  • Dsh also forms a complex with rac1 and mediates profilin binding to actin
  • rac1 activates JNK and also leads to actin polymerisation
  • this all leads to changes in planar cell polarity
34
Q

Where was PCP pathway first defined?

A
  • in Drosophila
  • the hairs are direct representation of neurons, the PCP pathway affects their polarity
  • PCP pathway regulates the prganised polarity of epidermal cells in the Drosophila wing
  • when you create a dsh mutant, the wing hair is non-organised
35
Q

What gives cells polarity?

A

-restricted distribution of PCP signalling

36
Q

What happens to cell polarity if you misregulate Dsh?

A

-wrong shape of cells

37
Q

What is the connection between convergent extension and neural tube closure?

A
  • convergent extension is required for initiation of neural tube closure
  • mouse mutants fail to initiate closure from Closure 1 and develop craniorachischisis
  • mutant genes encode proteins in PCP pathway, so get disruption of PCP signalling pathway
  • no convergent extension of the neural tube
  • neural tube is too broad to achieve closure
38
Q

What is the medial hinge point (MHP) in the 2. Elevation and apposition processes?

A

-overlies the notochors; bending of the upper neural plate

39
Q

What are the dorsolateral hinge points in 2. Elevation and apposition processes?

A

-point of attachment of the surface ectoderm and each neural fold; bending of the intermediate and lower neural plate

40
Q

What does the bending of the neuroepithelium in 2. Elevation and apposition involve?

A
  • changes in cell shape
  • neuroepithelial cells transform from spindle shaped to wedge shaped
  • apical narrowing and basal expansion
  • cell wedging is essential for neural plate bending
41
Q

What is the cellular mechanism for neural plate bending: Hypothesis 1?

A
  • Apical organisation of cytoskeletal actin-myosin microfilaments
  • purse string contraction of acto-myosin, reduction in the apical surface area
  • tested by disrupting the cytoskeleton by actin-disassembling drugs, this resulted in cranial NTDs
  • role in spinal neuralation remains unclear as the subjects treated woth actin-disassembling drugs did not develop spina bifida
42
Q

What is the cellular mechanism for neural plate bending: Hypothesis 2?

A
  • cells are widest at the position of the nucleus
  • cell cycle dependent variation in the apico-basal position of the cell nuclei
  • requirement for cell cycle regulation and nuclear migration remains unclear, so far untested
43
Q

What regulates the bending of the neural plate? (2. Apposition and elevation)

A
  • extracellular signalling
  • BMP signalling inhibits DLHP formation
  • sonic hedgehog, an intracellular signalling pathway, inhibits DLHP in the upper spine
44
Q

How does 3. Adhesion and fusion work?

A
  • few NTD models of adhesion/fusion
  • molecular mediators poorly understood
  • cell protrusions extend from the apical tips of the neural folds and provide cell-cell recognition and initial cell adhesion
  • neural fold midline fusion is thought to be achieved by adhesion molecules
45
Q

How does 4. Remodelling work?

A
  • separation of the neural tube and surface ectoderm is caused by differential adhesion of the two tissues
  • neural tube expresses neural cell adhesion molecule and neural (N)-cadherin
  • surface ectoderm expresses epithelial (E)-cadherin
  • cells will stick to the cells that have the same adhesion molecule. here have different so won’t stick together
  • disruption of N-cadherin expression in Xenopus causes defective neural tube closure
  • N-cadherin not essential for mammalian neuralation
46
Q

What is primary neuralation?

A
  • neural tube formed by shaping, bending and midline fusion
  • forms brain and majority of spinal cord
  • failure results in open neural tube defects
47
Q

What is secondary neurulation?

A
  • neural tube formed by cellular condensation and canalisation
  • forms the lowest part of the spinal cord
  • failure results in closed neural tube effects
48
Q

What does the failure of secondary neurulation result in?

A
  • closed neural tube defects
  • spinal dysraphis: closed NTD
  • least severe and least well defined group of NTDs
  • spinal cord is tethered to other tissues
  • faulty tissue separation
49
Q

What is the cellular mechanism of secondary neurulation?

A
  • mesenchymal cells condense and differentiate into neuroepithelium, generate the central lumen in the lower part of the neural tube
  • cells reorganise “canalisation” to form the central lumen of the secondary neural tube
  • lumen is continuous with primary neural tube
50
Q

What is the primary prevention of human NTDs?

A

-folic acid intake during the peri-conceptional period (women)

51
Q

What are the curent recommendations for folic acid intake?

A
  • 400 microgrammes per day for all women during the peri-conceptional period
  • folic acid 4-5 mg per day for all women at high risk of NTD
  • it is ensured by mandatory folic acid fortification in food
52
Q

Are many mothers folate deficient?

A

-no

53
Q

Do we understand how folic acid prevents NTDs?

A
  • very limited at best
  • folates are integral to one-carbon metabolism which produces pyramidines and purines for DNA synthesis
  • exogenous folic acid stimulates a cellular response to enable developing embryo to overcome NTD inducing genetic or environmental effects
54
Q

Are all human NTDs prevented by intake of folic acid?

A
  • no
  • a subset of NTDs are not prevented by folic acid supplementation
55
Q

What is the PONTI trial about?

A
  • testing if Inositol is successful in preventing NTDs
  • Inositol is the only vitamin-like molecula required for normal neural tube closure in rodents
  • some human NTD pregnancies have lowe maternal inositol concentrations than unaffected pregnancies
56
Q

What is the commonly used mouse model used for human neural tube defects?

A
  • Curly tail mouse
  • spontaneous mutant, partially penetrant NTDs
  • 15-20% spina bifida, 5% exencephaly
  • pathogenesis resembles human NTDs
  • non-responsive to folate acid
  • penetrance strongly influenced by genetic background and environmental factors
57
Q

What is the mechanism of spina bifida in the Curly tail mouse?

A
  • reduce cell proliferation in hindgut
  • increased curvature of body axis due to different rates of growth, mechanically delays the closure
  • delayed closure of neural folds
  • spina bifida and tail defects
    treatments: -rebalancing growth corrects spina bifida
  • splinting normalize neural tube closure
  • inositol prevents spina bifida

Grhl3 is the main causative gene

58
Q

What is Grainyhead-like genes needed for?

A
  • correct levels of Grainyhead-like gene 2 and 3 expression are required for normal neuralation (mice)
  • now looking for the Grainyhead-like 2 and 3 regulatory mutations in humans
59
Q

What is the causative genetic defect in the axial defects mouse?

A
  • up-regulation of Grhl2
  • reduction in Grhl2 expression rescues Axial defect phenotype

additional information:

  • adhesion proteins are miss-regulated in axial defect mouse model too
  • another adhesion

the surface ectoderm is too adhesive ti allow correct adhesion fusion and or remodelling

-GRHL2 may regulate adhesion proteins